Most people who are diagnosed with depression or bipolar disorder are prescribed one of the variety of medications available that can take many weeks to make any sort of difference. Not only that, many experience extreme side effects from these drugs.
When someone has a severe form of these diseases or is suicidal, a practically instantaneous treatment could save lives and change the clinical paradigm of psychiatry entirely.
That’s what Tal Medical is looking to do using Low Field Magnetic Stimulation, or LFMS, which is derived from a very specific type of MRI. Though still in clinical trial phase, they are seeing very promising results after brief 20-minute sessions.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
CEO Jan Skvarka shared about the developing technology Tal Medical is working during MedCity CONVERGE this week in Philadelphia.
Watch our CONVERGE NOW discussion here and below:
Photo: Flickr user darcyadelaide